abc biopply ag
Biotechnology Research • 
Solothurn, Solothurn, Switzerland • 1-10 Employees
Company overview
| Headquarters | Weissensteinstrasse 81, Solothurn, Solothurn 4500, CH |
| Phone number | +41417472550 |
| Website | |
| NAICS | 541714 |
| Keywords | Consulting, Cancer Research, Organoids, Primary Cells, Spheroids, 3D Cell Culture Technologies, 3D Cell Systems In Hts/Hcs, Cell Sourcing, Standardisation Of Cell Culture Protocols, 3D Lab Services, Preclinical Study Models |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Key Contact at abc biopply ag
Agne Vaitkeviciene
Director of Business Development
abc biopply ag Email Formats
abc biopply ag uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@biopply.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@biopply.com | 50% |
{first name}.{last name} | john.doe@biopply.com | 50% |
About abc biopply ag
abc biopply humanized disease models predict patient response to treatment Our proprietary technology creates hundreds of miniature versions of patient organs in a laboratory setting, using both healthy and diseased tissues. Our innovative models bridge the gap in predictability between the lab and the clinic. We free preclinical models from non-human components whenever possible Conventional cellular or animal disease models have shown that the predictability of patient response to treatment is severely limited. Great efforts have been made to humanize mouse models to better predict certain aspects of human physiology and immunology. The abc biopply team has made a significant breakthrough in humanizing upstream 3D cell models through the revolutionary and proprietary 3D CoSeedis multi-organoid in chip technology™. Thanks to exceptional physiological growth conditions and unique ways of intercellular communication, our models are free from non-human components to the greatest extent possible and allow us to mimic specific organs and tissues in culture over long periods of time. Thus, we successfully bridge the translational gap with unparalleled physiological responses and unique statistical predictive power.
abc biopply ag revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
abc biopply ag has never raised funding before.
abc biopply ag Tech Stack
Discover the technologies and tools that power abc biopply ag's digital infrastructure, from frameworks to analytics platforms.
Web servers
Programming languages
Security
Analytics
Slovenia
United Kingdom
Canada
United States
SwedenFrequently asked questions
4.8
40,000 users
